Page last updated: 2024-08-21

vancomycin and tazobactam

vancomycin has been researched along with tazobactam in 42 studies

Research

Studies (42)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	7 (16.67)	18.2507
2000's	7 (16.67)	29.6817
2010's	19 (45.24)	24.3611
2020's	9 (21.43)	2.80

Authors

Authors	Studies
Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S	1
Betschel, S; Kreiswirth, B; Low, DE; Willey, BM	1
Kinzig, M; Sörgel, F	1
Atwood, E; DiTore, V; Landman, D; Patel, K; Quale, J; Saurina, G	1
Palmer, SM; Rybak, MJ	1
Andremont, A; Guy, H; Marie, JP; Pico, JL; Richet, H; Vekhoff, A	1
Baudard, M; Bouvet, A; Chast, F; Delmer, A; Legrand, O; Levy, V; Marie, JP; Marjanovic, Z; Rio, B; Vekhoff, A; Zittoun, R	1
Caballero, D; Encinas, MP; García-Sanz, R; Gutiérrez, N; Hurlé, AD; Morín, LS; Vázquez, L; Vilches, P	1
Aznar, E; Climent, MA; Máiquez, J; Palau, J; Picón, I	1
Cross, JM; May, AK; McGwin, G; Melton, SM; Moser, SA; Rue, LW	1
Baddour, LM; Googe, PB; Prince, TL	1
Chin, NX; Della-Latta, P; Libre, PE	1
Glasmacher, A; Wade, JC	1
Al Hassan, M; Byrd, RP; Halawa, A; Roy, TM; Yacoub, G	1
Foley, RJ; Kannan, S; Kourelis, T	1
Bellomo, R; Cole, L; Lipman, J; Liu, X; Nair, P; Roberts, DM; Roberts, JA; Roberts, MS	1
Adams, CA; Cioffi, WG; Connolly, MD; Gregg, S; Heffernan, DS; Monaghan, SF; Stephen, A; Thakkar, RK	1
Fortier, LC; Garneau, JR; Valiquette, L	1
Listernick, R	1
Anderson, AM; Easley, K; Kandiah, S; Kim, T; Patel, M; Rab, S; Wong, J; Xue, W	1
Alp, E; Çetin, M; Elmali, F; Kaynar, L; Kürkçüoglu, CA; Metan, G; Yozgat, N	1
Manian, FA	1
Kaye, KS; Navalkele, B; Pogue, JM	1
Anderson, CW; Cazares, KS; Denunzio, TM; Lustik, MB; Patel, SM	1
Beckman, EJ	1
Downes, KJ; Fisher, BT; Laskin, BL	1
Jhaveri, R; Willis, ZI	1
Asano, T; Hirano, S; Imai, S; Kushiya, H; Miyasaka, D; Nakamura, T; Nakanishi, Y; Noji, T; Okamura, K; Shichinohe, T; Tanaka, K; Tsuchikawa, T	1
Leong, D; Wu, PE	1
Bergstrom, C; Gupta, A; Nagalla, S	1
Carreno, J; Hunter, C; Lomaestro, B; Smiraglia, T; Tobin, E	1
Blevins, AM; Juang, P; Kollef, M; Lashinsky, JN; McCammon, C; Micek, S	1
Banerjee, R; Esbenshade, AJ; Quach, HT; Zhao, Z	1
Campanile, A; Ciarambino, T; Giannico, OV; Giordano, M; Para, O; Signoriello, G; Tirelli, P	1
Lin, FJ; Shao, CH; Tai, CH; Wang, CC; Wang, JT; Wu, CC	1
Chiasson, JM; Cutrell, JB; Jodlowski, TZ; Kouma, MA; Smith, WJ	1
Bansal, R; Deshpande, AA; Jagia, P; Sharma, V	1
Amoureux, L; Casenaz, A; Guilloteau, A; Labattut, L; Magallon, A; Neuwirth, C; Piroth, L; Sixt, T	1
Alosaimy, S; Amaya, L; Biagi, M; Chandler, E; Cubillos, A; Davis, SL; Finch, N; Hobbs, ALV; Holger, D; Jorgensen, SCJ; Kufel, WD; Kunz Coyne, AJ; Lagnf, AM; Li, D; Molina, KC; Moore, WJ; Morrisette, T; Mubarez, M; Patch, M; Polisetty, RS; Rebold, N; Rico, M; Rybak, MJ; Sakoulas, G; Simon, SP; Smith, IMK; Tran, NN; Truong, J; Venugopalan, V; Veve, MP; Witucki, P; Wrin, J; Yost, C	1
Ankravs, MJ; Bellomo, R; Deane, AM; Rechnitzer, T; Roberts, JA; Sharrock, L; Wallis, SC	1
Li, J; Li, N; Liu, B; Lü, X; Wang, H; Zhang, Y	1
Caldwell, JT; Dong, S; Fei, L; Goldstein, SL; Hasson, D; Kaplan, J; Slagle, C; Tang Girdwood, S; Tang, P; Vinks, AA	1

Reviews

3 review(s) available for vancomycin and tazobactam

Article	Year
Enterococcis: pathogens of the 90s. The European journal of surgery. Supplement. : = Acta chirurgica. Supplement, 1994, Issue:573 Topics: Abdominal Abscess; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus; Gram-Positive Bacterial Infections; Humans; Penicillanic Acid; Piperacillin; Tazobactam; Vancomycin	1994
Pharmacokinetic characteristics of piperacillin/tazobactam. Intensive care medicine, 1994, Volume: 20 Suppl 3 Topics: beta-Lactamase Inhibitors; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Humans; Penicillanic Acid; Piperacillin; Tazobactam; Time Factors; Tissue Distribution; Tobramycin; Vancomycin	1994
Acute kidney injury and vancomycin/piperacillin/tazobactam in adult patients: a systematic review. Internal and emergency medicine, 2020, Volume: 15, Issue:2 Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Piperacillin; Tazobactam; Vancomycin	2020

Trials

5 trial(s) available for vancomycin and tazobactam

Article	Year
Neutropenic infections: a review of the French Febrile Aplasia Study Group trials in 608 febrile neutropenic patients. The Journal of antimicrobial chemotherapy, 1998, Volume: 41 Suppl D Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Fever; Hematologic Neoplasms; Humans; Multivariate Analysis; Neutropenia; Opportunistic Infections; Penicillanic Acid; Piperacillin; Tazobactam; Vancomycin	1998
Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin as empiric therapy for fever in severely neutropenic patients. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1999, Volume: 7, Issue:2 Topics: Adult; Anti-Bacterial Agents; Antineoplastic Agents; Bacteremia; Bacterial Infections; Case-Control Studies; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fever; Fever of Unknown Origin; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Penicillins; Piperacillin; Prospective Studies; Tazobactam; Tobramycin; Vancomycin	1999
Randomized prospective study comparing cost-effectiveness of teicoplanin and vancomycin as second-line empiric therapy for infection in neutropenic patients. Haematologica, 1999, Volume: 84, Issue:3 Topics: Amikacin; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Blood Chemical Analysis; Cost-Benefit Analysis; Drug Costs; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Safety; Tazobactam; Teicoplanin; Treatment Failure; Vancomycin	1999
Vancomycin does not benefit persistently febrile neutropenic people with cancer. Cancer treatment reviews, 2004, Volume: 30, Issue:1 Topics: Anti-Bacterial Agents; Double-Blind Method; Drug Therapy, Combination; Evidence-Based Medicine; Female; Fever; Follow-Up Studies; Humans; Male; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Probability; Proportional Hazards Models; Reference Values; Risk Assessment; Severity of Illness Index; Tazobactam; Treatment Outcome; Vancomycin	2004
Incidence of acute kidney injury among pediatric hematology/oncology patients receiving vancomycin in combination with piperacillin/tazobactam or cefepime. Pediatric blood & cancer, 2019, Volume: 66, Issue:7 Topics: Acute Kidney Injury; Adolescent; Cefepime; Child; Child, Preschool; Female; Hematologic Neoplasms; Humans; Male; Piperacillin; Retrospective Studies; Tazobactam; Vancomycin	2019

Other Studies

34 other study(ies) available for vancomycin and tazobactam

Article	Year
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:4 Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen	2007
Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1996, Volume: 23, Issue:5 Topics: Ampicillin; Disease Outbreaks; Drug Resistance, Microbial; Enterococcus; Enterococcus faecium; Gastrointestinal Diseases; Gram-Positive Bacterial Infections; Humans; Penicillanic Acid; Piperacillin; Sulbactam; Tazobactam; Vancomycin	1996
An evaluation of the bactericidal activity of ampicillin/sulbactam, piperacillin/tazobactam, imipenem or nafcillin alone and in combination with vancomycin against methicillin-resistant Staphylococcus aureus (MRSA) in time-kill curves with infected fibrin The Journal of antimicrobial chemotherapy, 1997, Volume: 39, Issue:4 Topics: Ampicillin; Anti-Bacterial Agents; Drug Synergism; Drug Therapy, Combination; Fibrin; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Nafcillin; Penicillanic Acid; Penicillins; Piperacillin; Staphylococcus aureus; Sulbactam; Tazobactam; Vancomycin	1997
[Cost of antibiotic therapy in neutropenic patients undergoing peripheral blood stem cell transplantation for breast cancer]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2000, Volume: 13, Issue:2 Topics: Amikacin; Antineoplastic Agents; Breast Neoplasms; Drug Costs; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hematopoietic Stem Cell Transplantation; Hospital Costs; Humans; Neutropenia; Penicillanic Acid; Piperacillin; Spain; Tazobactam; Teicoplanin; Transplantation Conditioning; Treatment Failure; Treatment Outcome; Vancomycin	2000
Reduction of vancomycin-resistant enterococcal infections by limitation of broad-spectrum cephalosporin use in a trauma and burn intensive care unit. Shock (Augusta, Ga.), 2000, Volume: 14, Issue:3 Topics: Burn Units; Cephalosporins; Clinical Protocols; Cross Infection; Drug Utilization; Enterococcus; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Methicillin Resistance; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Staphylococcal Infections; Staphylococcus aureus; Tazobactam; Vancomycin; Vancomycin Resistance; Wounds and Injuries	2000
Possible role of cellular immunity: a case of cellulitis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001, Volume: 32, Issue:1 Topics: Cellulitis; Clindamycin; Drug Eruptions; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Hypersensitivity, Delayed; Middle Aged; Nafcillin; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam; Vancomycin	2001
Intracameral antibiotic agents for endophthalmitis prophylaxis: a pharmacokinetic model. Journal of cataract and refractive surgery, 2003, Volume: 29, Issue:9 Topics: Anti-Bacterial Agents; Endophthalmitis; Enzyme Inhibitors; Eye; Half-Life; Humans; Methicillin Resistance; Penicillanic Acid; Piperacillin; Staphylococcal Infections; Staphylococcus aureus; Tazobactam; Vancomycin	2003
Dacryocystitis: an unusual form of Mucorales infection. The Journal of the Kentucky Medical Association, 2008, Volume: 106, Issue:11 Topics: Adult; Anti-Bacterial Agents; Dacryocystitis; Enzyme Inhibitors; Female; Humans; Mucorales; Mucormycosis; Penicillanic Acid; Piperacillin; Tazobactam; Tobramycin; Vancomycin	2008
An unusual case of septic shock in a geriatric patient. Connecticut medicine, 2010, Volume: 74, Issue:3 Topics: Aged, 80 and over; Anti-Bacterial Agents; Antidiuretic Agents; Capnocytophaga; Female; Fluid Therapy; Gram-Negative Bacterial Infections; Humans; Multiple Organ Failure; Penicillanic Acid; Piperacillin; Risk Factors; Shock, Septic; Tazobactam; Vancomycin; Vasopressins	2010
Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study. Critical care medicine, 2012, Volume: 40, Issue:5 Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Ciprofloxacin; Critical Illness; Female; Hemofiltration; Humans; Male; Meropenem; Middle Aged; Penicillanic Acid; Piperacillin; Tazobactam; Thienamycins; Vancomycin	2012
Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops. The Journal of surgical research, 2013, Volume: 181, Issue:2 Topics: Acetamides; Anti-Bacterial Agents; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Cefepime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Penicillanic Acid; Piperacillin; Pneumonia, Ventilator-Associated; Retrospective Studies; Tazobactam; Treatment Outcome; Vancomycin; Wounds and Injuries	2013
Prevention of Clostridium difficile spore formation by sub-inhibitory concentrations of tigecycline and piperacillin/tazobactam. BMC infectious diseases, 2014, Jan-15, Volume: 14 Topics: Anti-Bacterial Agents; Ciprofloxacin; Clostridioides difficile; Humans; Metronidazole; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Ribotyping; Spores, Bacterial; Tazobactam; Tigecycline; Vancomycin	2014
A 13-Year-Old Boy with Pancytopenia and a Sacrococcygeal Abscess. Pediatric annals, 2015, Volume: 44, Issue:9 Topics: Abscess; Adolescent; Anti-Bacterial Agents; Diagnosis, Differential; Glucocorticoids; Humans; Male; Pancytopenia; Penicillanic Acid; Piperacillin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Sacrococcygeal Region; Tazobactam; Vancomycin	2015
Risk factors for kidney injury during vancomycin and piperacillin/tazobactam administration, including increased odds of injury with combination therapy. BMC research notes, 2015, Oct-17, Volume: 8 Topics: Acute Kidney Injury; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Multivariate Analysis; Penicillanic Acid; Piperacillin; Regression Analysis; Risk Factors; Tazobactam; Vancomycin	2015
A change for the antibacterial treatment policy to decrease carbapenem consumption at a haematopoietic stem cell transplantation centre. Le infezioni in medicina, 2017, Mar-01, Volume: 25, Issue:1 Topics: Amikacin; Anti-Bacterial Agents; Carbapenems; Cross Infection; Febrile Neutropenia; Guidelines as Topic; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Penicillanic Acid; Piperacillin; Retrospective Studies; Tazobactam; Teicoplanin; Tertiary Care Centers; Treatment Outcome; Turkey; Vancomycin	2017
Should We Revisit the Nephrotoxic Potential of Piperacillin-Tazobactam as Well? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017, 07-01, Volume: 65, Issue:1 Topics: Acute Kidney Injury; Cefepime; Humans; Piperacillin; Tazobactam; Vancomycin	2017
Reply to Manian. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017, 07-01, Volume: 65, Issue:1 Topics: Acute Kidney Injury; Cefepime; Humans; Piperacillin; Tazobactam; Vancomycin	2017
Vancomycin vs. Vancomycin/Piperacillin-Tazobactam-Associated Acute Kidney Injury in Noncritically Ill Patients at a Tertiary Care Military Treatment Facility. Military medicine, 2017, Volume: 182, Issue:9 Topics: Acute Kidney Injury; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Hospitals, Military; Humans; Incidence; Logistic Models; Male; Middle Aged; Military Personnel; Odds Ratio; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Tazobactam; Tertiary Care Centers; Vancomycin	2017
Piperacillin-Tazobactam Plus Vancomycin Equals Acute Kidney Injury: Does It Add Up? Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2017, Volume: 18, Issue:12 Topics: Acute Kidney Injury; Child; Critical Illness; Humans; Piperacillin; Tazobactam; Vancomycin	2017
The Cost of Vancomycin and Piperacillin/Tazobactam Treatment-Reply. JAMA pediatrics, 2018, 05-01, Volume: 172, Issue:5 Topics: Acute Kidney Injury; Child; Child, Hospitalized; Humans; Piperacillin; Tazobactam; Vancomycin	2018
The Cost of Vancomycin and Piperacillin/Tazobactam Treatment. JAMA pediatrics, 2018, 05-01, Volume: 172, Issue:5 Topics: Acute Kidney Injury; Child; Child, Hospitalized; Humans; Piperacillin; Tazobactam; Vancomycin	2018
The use of broad-spectrum antibiotics reduces the incidence of surgical site infection after pancreatoduodenectomy. Surgery today, 2018, Volume: 48, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Cefmetazole; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Incidence; Intraoperative Period; Male; Middle Aged; Pancreaticoduodenectomy; Penicillanic Acid; Piperacillin; Retrospective Studies; Surgical Wound Infection; Tazobactam; Time Factors; Vancomycin	2018
Acute Kidney Injury Due to Concomitant Vancomycin and Piperacillin-Tazobactam. JAMA internal medicine, 2018, 08-01, Volume: 178, Issue:8 Topics: Acute Kidney Injury; Febrile Neutropenia; Humans; Penicillanic Acid; Piperacillin; Tazobactam; Vancomycin	2018
Acute Kidney Injury Due to Concomitant Vancomycin and Piperacillin-Tazobactam-Reply. JAMA internal medicine, 2018, 08-01, Volume: 178, Issue:8 Topics: Acute Kidney Injury; Febrile Neutropenia; Humans; Penicillanic Acid; Piperacillin; Tazobactam; Vancomycin	2018
Comparative incidence and excess risk of acute kidney injury in hospitalised patients receiving vancomycin and piperacillin/tazobactam in combination or as monotherapy. International journal of antimicrobial agents, 2018, Volume: 52, Issue:5 Topics: Academic Medical Centers; Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Creatinine; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Female; Hospital Mortality; Humans; Incidence; Length of Stay; Male; Middle Aged; New York; Piperacillin; Retrospective Studies; Risk Assessment; Tazobactam; Vancomycin; Young Adult	2018
Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam, Cefepime, or Meropenem. Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:5 Topics: Acute Kidney Injury; Aged; Cefepime; Critical Illness; Female; Humans; Incidence; Male; Meropenem; Middle Aged; Multivariate Analysis; Piperacillin; Retrospective Studies; Tazobactam; Vancomycin	2019
Comparison of risk of acute kidney injury between patients receiving the combination of teicoplanin and piperacillin/tazobactam versus vancomycin and piperacillin/tazobactam. Journal of the Formosan Medical Association = Taiwan yi zhi, 2022, Volume: 121, Issue:1 Pt 1 Topics: Acute Kidney Injury; Humans; Piperacillin; Retrospective Studies; Tazobactam; Teicoplanin; Vancomycin	2022
Impact of a Rapid Blood Culture Diagnostic Panel on Time to Optimal Antimicrobial Therapy at a Veterans Affairs Medical Center. Journal of pharmacy practice, 2022, Volume: 35, Issue:5 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Blood Culture; Cohort Studies; Humans; Piperacillin; Retrospective Studies; Tazobactam; Vancomycin; Veterans	2022
Tension pericardial abscess in a patient with tuberculosis: a rare cause of cardiac tamponade. Lancet (London, England), 2021, 06-12, Volume: 397, Issue:10291 Topics: Abscess; Anti-Bacterial Agents; Cardiac Tamponade; Humans; Male; Pericardiocentesis; Pericardium; Piperacillin; Pneumopericardium; Tazobactam; Tuberculosis, Lymph Node; Vancomycin; Young Adult	2021
Epidemiology and antibiotic resistance of prosthetic joint infections according to time of occurrence, a 10-year study. The Journal of infection, 2022, Volume: 85, Issue:5 Topics: Anti-Bacterial Agents; Arthritis, Infectious; Cefotaxime; Coagulase; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans; Imipenem; Microbial Sensitivity Tests; Piperacillin; Prosthesis-Related Infections; Retrospective Studies; Staphylococcus aureus; Tazobactam; Vancomycin	2022
Nephrotoxicity of Vancomycin in Combination With Beta-Lactam Agents: Ceftolozane-Tazobactam vs Piperacillin-Tazobactam. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023, 02-08, Volume: 76, Issue:3 Topics: Acute Kidney Injury; Anti-Bacterial Agents; beta-Lactams; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Humans; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Tazobactam; Vancomycin	2023
Clearance of Piperacillin-Tazobactam and Vancomycin During Continuous Renal Replacement With Regional Citrate Anticoagulation. Therapeutic drug monitoring, 2023, 04-01, Volume: 45, Issue:2 Topics: Acute Kidney Injury; Anti-Bacterial Agents; Anticoagulants; Citrates; Citric Acid; Critical Illness; Humans; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam; Vancomycin	2023
Antibiotic susceptibility and biofilm-forming ability of Veillonella strains. Anaerobe, 2022, Volume: 78 Topics: Ampicillin; Anti-Bacterial Agents; Biofilms; Cefoxitin; Clindamycin; Humans; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Piperacillin; Tazobactam; Tetracyclines; Vancomycin; Veillonella	2022
Relationship between piperacillin concentrations, clinical factors and piperacillin/tazobactam-associated acute kidney injury. The Journal of antimicrobial chemotherapy, 2023, 02-01, Volume: 78, Issue:2 Topics: Acute Kidney Injury; Anti-Bacterial Agents; Child; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Tazobactam; Vancomycin; Young Adult	2023